SHANU MODI

Allopathic & Osteopathic Physicians|Internal Medicine|Medical Oncology NEW YORK, NY NPI 1346211141

General Payments — all program years on this page

$304,605.66

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 199
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $60,798.03 across 30 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $46,911.2014
Travel and Lodging $11,476.664
Honoraria $1,150.001
Food and Beverage $910.1710
Grant $350.001

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
AstraZeneca UK Limited $21,577.505
Daiichi Sankyo Europe GmbH $12,360.304
Daiichi Sankyo Company LTD $7,968.001
F. Hoffmann-La Roche AG $5,193.924
Acerta Pharma LLC $3,953.077
Daiichi Sankyo Inc. $3,332.374
BioNTech SE $2,538.001
E.R. Squibb & Sons, L.L.C. $2,478.202
PFIZER INC. $1,150.001
JAZZ PHARMACEUTICALS INC. $246.671

By program year

Program yearAmountRecords
2018 $24,591.2521
2019 $33,885.5130
2020 $48,499.3438
2021 $47,034.5321
2022 $28,558.4525
2023 $61,238.5534
2024 $60,798.0330

Records — PY2024 (30)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1075869842 Daiichi Sankyo Company LTD $7,968.00 04/22/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1089458330 Daiichi Sankyo Inc. $1,712.50 07/31/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089458332 Daiichi Sankyo Inc. $1,455.00 03/21/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1089458334 Daiichi Sankyo Inc. $30.00 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1089458344 Daiichi Sankyo Inc. $134.87 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091119877 Daiichi Sankyo Europe GmbH $9,215.00 04/16/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1091119879 Daiichi Sankyo Europe GmbH $1,945.00 04/16/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1091119909 Daiichi Sankyo Europe GmbH $954.12 03/03/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1091119911 Daiichi Sankyo Europe GmbH $246.18 03/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1093891355 AstraZeneca UK Limited $2,055.00 09/02/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093895372 AstraZeneca UK Limited $685.00 08/29/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1093940486 AstraZeneca UK Limited $1,370.00 06/28/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1094005596 AstraZeneca UK Limited $685.00 12/10/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1094015593 AstraZeneca UK Limited $16,782.50 05/22/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101269889 E.R. Squibb & Sons, L.L.C. $2,428.20 12/30/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1101269897 E.R. Squibb & Sons, L.L.C. $50.00 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104331334 AstraZeneca Pharmaceuticals LP $48.09 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104447189 AstraZeneca Pharmaceuticals LP $350.00 01/03/2024 Grant Undisputed 01/23/2026 View at CMS
1104669425 AstraZeneca Pharmaceuticals LP $25.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105386912 AstraZeneca Pharmaceuticals LP $29.98 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105400438 AstraZeneca Pharmaceuticals LP $1,370.00 10/17/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1105414768 AstraZeneca Pharmaceuticals LP $75.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105675179 AstraZeneca Pharmaceuticals LP $2,055.00 07/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1131482043 PFIZER INC. $1,150.00 01/04/2024 Honoraria Undisputed 01/23/2026 View at CMS
1133111348 F. Hoffmann-La Roche AG $760.00 12/01/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133111352 F. Hoffmann-La Roche AG $609.54 09/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1133111356 F. Hoffmann-La Roche AG $3,800.00 09/13/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1133111360 F. Hoffmann-La Roche AG $24.38 09/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150210549 JAZZ PHARMACEUTICALS INC. $246.67 06/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150660506 BioNTech SE $2,538.00 04/03/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.